We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Purpose: Flavopiridol is the first cyclin-dependent kinase inhibitor to enter clinical trials.
2
The results implicate a putative cyclin-dependent kinase in the control of development.
3
The other three mutants caused phenotypes dependent on the particular cyclin-dependent kinase.
4
This review describes the mechanisms of these new functions of cyclin D1.
5
Tissue from the same 10 patients contained viral cyclin on PCR analysis.
1
TARA regulates CycA protein levels and genetically and physically interacts with CycA to promote sleep.
2
We propose that TARANIS controls sleep amount by regulating CycA protein levels and inhibiting Cdk1 activity in a novel arousal center.
3
Anyone who attended the CYCA at the following times is asked to monitor for symptoms and get a test if they develop symptoms.
4
We report here that there are four cycA transcripts by high-resolution Northern (RNA) blot analysis, and we have mapped 10 5' ends by primer extension.